Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction

Mutagenesis

Volumn 25, Issue 5, 2010, Pages 489-498

  Furness, D L F ^a,b   Dekker, G A ^a   Hague, W M ^a   Khong, T Y ^a   Fenech, M F ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOLOGICAL MONITORING; CHROMOSOME DAMAGE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINESIS; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LYMPHOCYTE; MICRONUCLEUS; PERIPHERAL LYMPHOCYTE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL GROWTH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SYMPTOM;

ADULT; AGING; BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; CYTOKINESIS; DNA DAMAGE; FEMALE; FETAL GROWTH RETARDATION; HUMANS; LYMPHOCYTES; MICRONUCLEI, CHROMOSOME-DEFECTIVE; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 77956253491     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq032     Document Type: Article

References (82)

1. Vinson, R. K. and Hales, B. F. (2002) DNA repair during organogenesis. Mutat. Res., 509, 79-91.
2. Fenech, M. (2007) Genome health nutrigenomics and nutrigenetics- diagnosis and nutritional treatment of genome damage on an individual basis. Food Chem. Toxicol, 46, 1365-1370.
3. Fenech, M. (2005) The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis, 20, 255-269.
4. Sankoff, D., Deneault, M., Turbis, P. and Allen, C. (2002) Chromosomal distributions of breakpoints in cancer, infertility, and evolution. Theor. Popul. Biol., 61, 497-501.
5. Trkova, M., Kapras, J., Bobkova, K., Stankova, J. and Mejsnarova, B. (2000) Increased micronuclei frequencies in couples with reproductive failure. Reprod. Toxicol., 14, 331-335.
6. Warren, J. E. and Silver, R. M. (2008) Genetics of pregnancy loss. Clin. Obstet. Gynecol., 51, 84-95.
7. Morawiec, Z., Janik, K., Kowalski, M., Stetkiewicz, T., Szaflik, J., Morawiec-Bajda, A., Sobczuk, A. and Blasiak, J. (2008) DNA damage and repair in children with Downs syndrome. Mutat. Res., 637, 118-123.
8. Izraeli, S. (2006) Perspective: chromosomal aneuploidy in leukemia- lessons from down syndrome. Hematol. Oncol., 24, 3-6.
9. Aitken, R. J., Skakkebaek, N. E. and Roman, S. D. (2006) Male reproductive health and the environment. Med. J. Aust., 185, 414-415.
10. Aitken, R. J., De Iuliis, G. N. and McLachlan, R. I. (2009) Biological and clinical significance of DNA damage in the male germ line. Int. J. Androl., 32, 46-56.
11. Khong, T. Y. (1991) The Robertson-Brosens-Dixon hypothesis: evidence for the role of haemochorial placentation in pregnancy success. Br. J. Obstet. Gynaecol., 98, 1195-1199.
12. Sibai, B., Dekker, G. and Kupferminc, M. (2005) Pre-eclampsia. Lancet, 365, 785-799.
13. Dekker, G. A. and Sibai, B. M. (1998) Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol., 179, 1359-1375.
14. Sizonenko, S. V., Borradori-Tolsa, C., Bauthay, D. M., Lodygensky, G., Lazeyras, F. and Huppi, P. (2006) Impact of intrauterine growth restriction and glucocorticoids on brain development: insights using advanced magnetic resonance imaging. Mol. Cell. Endocrinol., 254-255, 163-171.
15. Bernstein, I. M., Horbar, J. D., Badger, G. J., Ohlsson, A. and Golan, A. (2000) Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am. J. Obstet. Gynecol., 182, 198-206.
16. Prada, J. A. and Tsang, R. C. (1998) Biological mechanisms of environmentally induced causes of IUGR. Eur. J. Clin. Nutr., 52 (Suppl 1), S21-S27discussion, S27-S28.
17. Baserga, M., Hale, M. A., Wang, Z. M., Yu, X., Callaway, C. W., McKnight, R. A. and Lane, R. H. (2007) Uteroplacental insufficiency alters nephrogenesis and downregulates cyclooxygenase-2 expression in a model of IUGR with adult-onset hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol., 292, R1943-R1955.
18. Barker, D. J. (2004) The developmental origins of well-being. Philos. Trans. R. Soc. Lond. B Biol. Sci., 359, 1359-1366.
19. Frederick, I. O., Rudra, C. B., Miller, R. S., Foster, J. C. and Williams, M. A. (2006) Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology, 17, 428-434.
20. Moran, C., Sandoval, T., Duque, X., Gonzalez, S., Moran, S. and Bermudez, J. A. (2006) Increased insulin levels independent of gestational overweight in women with preeclampsia. Arch. Med. Res., 37, 749-754.
21. Sibai, B. M. (2007) Imitators of severe preeclampsia. Obstet. Gynecol., 109, 956-966.
22. Makedos, G., Papanicolaou, A., Hitoglou, A., Kalogiannidis, I., Makedos, A., Vrazioti, V. and Goutzioulis, M. (2007) Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Arch. Gynecol. Obstet., 275, 121-124.
23. Kennare, R., Heard, A. and Chan, A. (2005) Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia. Aust. N. Z. J. Obstet. Gynaecol., 45, 220-225.
24. Shankaran, S., Lester, B. M., Das, A., Bauer, C. R., Bada, H. S., Lagasse, L. and Higgins, R. (2007) Impact of maternal substance use during pregnancy on childhood outcome. Semin. Fetal. Neonatal. Med., 12, 143-150.
25. Demirbag, R., Yilmaz, R., Gur, M., Celik, H., Guzel, S., Selek, S. and Kocyigit, A. (2006) DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int. J. Clin. Pract., 60, 1187-1193.
26. Fenech, M., Aitken, C. and Rinaldi, J. (1998) Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis, 19, 1163-1171.
27. Maffei, F., Fimognari, C., Castelli, E., Stefanini, G. F., Forti, G. C. and Hrelia, P. (2000) Increased cytogenetic damage detected by FISH analysis on micronuclei in peripheral lymphocytes from alcoholics. Mutagenesis, 15, 517-523.
28. Reddy Thavanati, P. K., Kanala, K. R., de Dios, A. E. and Cantu Garza, J. M. (2008) Age-related correlation between antioxidant enzymes and DNA damage with smoking and body mass index. J. Gerontol. A Biol. Sci. Med. Sci., 63, 360-364.
29. Srb, V. and Puza, V. (1975) [Methods for the analysis of human chromosome aberrations (authors transl)]. Cas. Lek. Cesk., 114, 231-236.
30. International Atomic Energy Agency (2001) Biological dosimetry: chromosomal aberrations analysis for dose assessment. Technical Report Series No. 405. International Atomic Energy Agency, Vienna, Austria.
31. Albertini, R. J., Anderson, D., Douglas, G. R. et al. (2000) IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat. Res., 463, 111-172.
32. Fenech, M. (2007) Cytokinesis-block micronucleus cytome assay. Nat. Protoc., 2, 1084-1104.
33. Bonassi, S., Fenech, M., Lando, C. et al. (2001) Human MicroNucleus project: international database comparison for results with the cytokinesisblock micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ. Mol. Mutagen., 37, 31-45.
34. Fenech, M. (2006) Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat. Res., 600, 58-66.
35. Bonassi, S., Ugolini, D., Kirsch-Volders, M., Stromberg, U., Vermeulen, R. and Tucker, J. D. (2005) Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ. Mol. Mutagen., 45, 258-270.
36. Bonassi, S., Hagmar, L., Stromberg, U. et al. (2000) Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res., 60, 1619-1625.
37. Rossner, P., Boffetta, P., Ceppi, M., Bonassi, S., Smerhovsky, Z., Landa, K., Juzova, D. and Sram, R. J. (2005) Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ. Health Perspect., 113, 517-520.
38. Federici, C., Botto, N., Manfredi, S., Rizza, A., Del Fiandra, M. and Andreassi, M. G. (2008) Relation of increased chromosomal damage to future adverse cardiac events in patients with known coronary artery disease. Am. J. Cardiol., 102, 1296-1300.
39. Migliore, L., Botto, N., Scarpato, R., Petrozzi, L., Cipriani, G. and Bonuccelli, U. (1999) Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet. Cell Genet., 87, 41-46.
40. Migliore, L., Scarpato, R., Coppede, F., Petrozzi, L., Bonuccelli, U. and Rodilla, V. (2001) Chromosome and oxidative damage biomarkers in lymphocytes of Parkinsons disease patients. Int. J. Hyg. Environ. Health, 204, 61-66.
41. Govindaiah, V., Naushad, S. M., Prabhakara, K., Krishna, P. C. and Radha Rama Devi, A. (2008) Association of parental hyperhomocysteinemia and C677T Methylene tetrahydrofolate reductase (MTHFR) polymorphism with recurrent pregnancy loss. Clin. Biochem, 42, 380-386.
42. Levario-Carrillo, M., Sordo, M., Rocha, F., Gonzalez-Horta, C., Amato, D. and Ostrosky-Wegman, P. (2005) Micronucleus frequency in human umbilical cord lymphocytes. Mutat. Res., 586, 68-75.
43. Brown, M. A., Hague, W. M., Higgins, J., Lowe, S., McCowan, L., Oats, J., Peek, M. J., Rowan, J. A. and Walters, B. N. (2000) The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust. N. Z. J. Obstet. Gynaecol., 40, 139-155.
44. Gestation Network. (2007) Birthweight Centile Calculator, Perinatal Institute. www.gestation.net (accessed, 2007).
45. Furness, D. L., Fenech, M. F., Khong, Y. T., Romero, R. and Dekker, G. A. (2008) One-carbon metabolism enzyme polymorphisms and uteroplacental insufficiency. Am. J. Obstet. Gynecol., 199, e271-e278.
46. Fenech, M. (1998) Important variables that influence base-line micronucleus frequency in cytokinesis-blocked lymphocytes-a biomarker for DNA damage in human populations. Mutat. Res., 404, 155-165.
47. Fenech, M. and Morley, A. A. (1986) Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiation. Mutat. Res., 161, 193-198.
48. Brenner, D. J., Doll, R., Goodhead, D. T. et al. (2003) Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc. Natl Acad. Sci. USA, 100, 13761-13766.
49. Deeks, J. J. and Altman, D. G. (2004) Diagnostic tests 4: likelihood ratios. BMJ, 329, 168-169.
50. Dekker, G. A., de Vries, J. I., Doelitzsch, P. M., Huijgens, P. C., von Blomberg, B. M., Jakobs, C. and van Geijn, H. P. (1995) Underlying disorders associated with severe early-onset preeclampsia. Am. J. Obstet. Gynecol., 173, 1042-1048.
51. Shichiri, M., Yoshinaga, K., Hisatomi, H., Sugihara, K. and Hirata, Y. (2002) Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res., 62, 13-17.
52. Rajagopalan, H. and Lengauer, C. (2004) Aneuploidy and cancer. Nature, 432, 338-341.
53. Xu, G. L., Bestor, T. H., Bourchis, D. et al. (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature, 402, 187-191.
54. Kaushal, D., Contos, J. J., Treuner, K. et al. (2003) Alteration of gene expression by chromosome loss in the postnatal mouse brain. J. Neurosci., 23, 5599-5606.
55. Rubio, C., Pehlivan, T., Rodrigo, L., Simon, C., Remohi, J. and Pellicer, A. (2005) Embryo aneuploidy screening for unexplained recurrent miscarriage: a minireview. Am. J. Reprod. Immunol., 53, 159-165.
56. Bianco, K., Caughey, A. B., Shaffer, B. L., Davis, R. and Norton, M. E. (2006) History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy. Obstet. Gynecol., 107, 1098-1102.
57. Fenech, M. (2002) Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov. Today, 7, 1128-1137.
58. Schupp, N., Schmid, U., Rutkowski, P., Lakner, U., Kanase, N., Heidland, A. and Stopper, H. (2007) Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am. J. Physiol. Renal. Physiol., 292, F1427-F1434.
59. Botto, N., Rizza, A., Colombo, M. G., Mazzone, A. M., Manfredi, S., Masetti, S., Clerico, A., Biagini, A. and Andreassi, M. G. (2001) Evidence for DNA damage in patients with coronary artery disease. Mutat. Res., 493, 23-30.
60. Bonassi, S., Znaor, A., Ceppi, M. et al. (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28, 625-631.
61. Murgia, E., Ballardin, M., Bonassi, S., Rossi, A. M. and Barale, R. (2008) Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat. Res., 639, 27-34.
62. Moran, L. J., Noakes, M., Clifton, P. M., Norman, R. J. and Fenech, M. F. (2008) Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat. Res., 639, 55-63.
63. Di Giorgio, C., De Meo, M. P., Laget, M., Guiraud, H., Botta, A. and Dumenil, G. (1994) The micronucleus assay in human lymphocytes: screening for inter-individual variability and application to biomonitoring. Carcinogenesis, 15, 313-317.
64. Bonassi, S., Neri, M., Lando, C. et al. (2003) Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus project. Mutat. Res., 543, 155-166.
65. Cindrova-Davies, T. (2009) Gabor Than Award Lecture 2008: preeclampsia- from placental oxidative stress to maternal endothelial dysfunction. Placenta, 30 (Suppl A), S55-S65.
66. Milosevic-Ethordevic, O., Grujicic, D., Marinkovic, D., Arsenijevic, S. and Bankovic, S. (2003) Effect of various doses of gestogens on micronuclei frequency in human peripheral blood lymphocytes of pregnant women. Hum. Reprod., 18, 433-436.
67. Maloney, C. A. and Rees, W. D. (2005) Gene-nutrient interactions during fetal development. Reproduction, 130, 401-410.
68. Fenech, M. (2001) Recommended dietary allowances (RDAs) for genomic stability. Mutat. Res., 480-481, 51-54.
69. Fenech, M., Baghurst, P., Luderer, W., Turner, J., Record, S., Ceppi, M. and Bonassi, S. (2005) Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability-results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis, 26, 991-999.
70. Sacks, G. P., Studena, K., Sargent, K. and Redman, C. W. (1998) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol., 179, 80-86.
71. Scholl, T. O. (2008) Maternal nutrition before and during pregnancy. Nestle Nutr. Workshop Ser Pediatr. Program, 61, 79-89.
72. Fletcher, R. H. and Fairfield, K. M. (2002) Vitamins for chronic disease prevention in adults: clinical applications. JAMA, 287, 3127-3129.
73. Umegaki, K. and Fenech, M. (2000) Cytokinesis-block micronucleus assay in WIL2-NS cells: a sensitive system to detect chromosomal damage induced by reactive oxygen species and activated human neutrophils. Mutagenesis, 15, 261-269.
74. Botto, N., Andreassi, M. G., Manfredi, S., Masetti, S., Cocci, F., Colombo, M. G., Storti, S., Rizza, A. and Biagini, A. (2003) Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur. J. Hum. Genet., 11, 671-678.
75. Roubicek, D. A., Gutierrez-Castillo, M. E., Sordo, M., Cebrian- Garcia, M. E. and Ostrosky-Wegman, P. (2007) Micronuclei induced by airborne particulate matter from Mexico City. Mutat. Res., 631, 9-15.
76. Song, E. Y., Rizvi, S. M., Qu, C. F., Raja, C., Yuen, J., Li, Y., Morgenstern, A., Apostolidis, C. and Allen, B. J. (2008) The cytokinesisblock micronucleus assay as a biological dosimeter for targeted alpha therapy. Phys. Med. Biol., 53, 319-328.
77. Ishikawa, H., Ishikawa, T., Yamamoto, H., Fukao, A. and Yokoyama, K. (2007) Genotoxic effects of alcohol in human peripheral lymphocytes modulated by ADH1B and ALDH2 gene polymorphisms. Mutat. Res., 615, 134-142.
78. Pedersen, M., Wichmann, J., Autrup, H. et al. (2009) Increased micronuclei and bulky DNA adducts in cord blood after maternal exposures to trafficrelated air pollution. Environ. Res., 109, 1012-1020.
79. Arab, K., Pedersen, M., Nair, J., Meerang, M., Knudsen, L. E. and Bartsch, H. (2009) Typical signature of DNA damage in white blood cells: a pilot study on etheno adducts in Danish mother-newborn child pairs. Carcinogenesis, 30, 282-285.
80. Dhillon, V., Thomas, P. and Fenech, M. (2009) Effect of common polymorphisms in folate uptake and metabolism genes on frequency of micronucleated lymphocytes in a South Australian cohort. Mutat. Res., 665, 1-6.
81. Touil, N., Elhajouji, A., Thierens, H. and Kirsch-Volders, M. (2000) Analysis of chromosome loss and chromosome segregation in cytokinesisblocked human lymphocytes: non-disjunction is the prevalent mistake in chromosome segregation produced by low dose exposure to ionizing radiation. Mutagenesis, 15, 1-7.
82. Lindberg, H. K., Wang, X., Jarventaus, H., Falck, G. C., Norppa, H. and Fenech, M. (2007) Origin of nuclear buds and micronuclei in normal and folate-deprived human lymphocytes. Mutat. Res., 617, 33-45.